Long Term: Veeva Systems: regulated CRM switching costs
Explore this signal
Long Term at a glance
Short reader summary
If drug makers adopt Vault CRM and Veeva agents together, regulated workflows could lift recurring subscriptions before the separate AI contribution becomes visible in reported cash.
Exact asset or item
Veeva Systems
Asset type
Listed investment
Reference price
301.53
Currency code
USD
Price observed at
2026-11-13T16:00:00-05:00
What this number represents
Tracking price
What remains unproven
Historical tracking close, not a purchase or current executable quote. AI revenue contribution and future returns are not established.
Exact asset or item
Exact asset or item
Veeva Systems
Asset type
Listed investment
Ticker
VEEV
Exchange
NYSE
How to identify this exact asset
Category: Shares Exact asset: NYSE: VEEV Country and currency: United States / USD Published: 15 November 2026, 15:58 SGT Information cutoff: 15 November 2026, 15:58 SGT Main time horizon: 2 years Current position: RESEARCH WATCH: revenue durability established, incremental AI revenue not isolated
Price and what it means
Entry or reference price
301.53
Currency code
USD
Price observed at
2026-11-13T16:00:00-05:00
What this number represents
Tracking price
Price evidence status
Verified
Price source
8. VEEV dated trading history | Stock Analysis | Original: 13 Nov 2026 quote | US / English.
Publisher: Stock Analysis
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-11-13
Source retrieval date 2026-11-16
Matching price source ID
VEEV-S8
Purchase, sale and realised profit
Original entry price and date (permanent, frozen field): US$301.53 per share, 13 Nov 2026 16:00 EST, US market closing reference; original source: https://stockanalysis.com/stocks/veev/history/. Latest checked price: same closing price only; no later independent regular-session quote available as of report cutoff. Price change: 0.00% since frozen tracking snapshot only, not an actual investment return. Estimated result after costs: NOT ASSESSABLE; unknown broker spread, commission, custody, FX, distributions and taxes; no costs were incurred by this research. Actually sold? NO, no purchase executed. Forecast status: NOT YET DUE; these are first-publication scenarios. Next review: 2026-12-03. Do not rewrite the frozen original price or forecast when new evidence appears; append a separately dated update.
The developments we connected
Separate development
What changed
125+ live customers
Date of the development
Evidence status
Observed
What the evidence shows
125+ live customers
Source IDs
- VEEV-S3
What changed
Fiscal Q2 reported revenue
Date of the development
Evidence status
Observed
What the evidence shows
Fiscal Q2 reported revenue
Source IDs
- VEEV-S1
What changed
190 live customers and new selection
Date of the development
Evidence status
Observed
What the evidence shows
190 live customers and new selection
Source IDs
- VEEV-S4
Emerging insight
REPORT A (3 March): more than 125 regulated firms have migrated to a working CRM. -> REPORT B (26 August): subscription revenue is already growing at the issuer level. -> REPORT C (23 September): new commitments may deepen the installed base. HIDDEN TEST: if additional agent features attach to migrations without a proportional rise in implementation cost, Veeva could earn more subscription income per customer. The public reports do not prove that separate agent subscriptions already generate material revenue.
How this exact asset could benefit
Beneficiary: Veeva Systems, selling subscription software for biopharma commercial and development workflows. Proven: company-level subscription sales and reported Vault CRM live deployments. Not proven: the incremental annual recurring revenue, margin or cash from agents specifically, plus how quickly newly selected clients go live. A repeatable multi-year subscription could support future earnings if customers renew; price appreciation is not guaranteed.
Who could benefit
Who
Veeva Systems
How they could benefit
Beneficiary: Veeva Systems, selling subscription software for biopharma commercial and development workflows. Proven: company-level subscription sales and reported Vault CRM live deployments. Not proven: the incremental annual recurring revenue, margin or cash from agents specifically, plus how quickly newly selected clients go live. A repeatable multi-year subscription could support future earnings if customers renew; price appreciation is not guaranteed.
Evidence status
Still unproven
What we observed
3 March 2026: Veeva said more than 125 customers were live on Vault CRM. 3 June: it reported fiscal-2027 Q1 revenue of approximately US$882.9m. 26 August: fiscal Q2 revenue rose to approximately US$928m, including US$766.8m subscription revenue. 23 September: Veeva said approximately 190 customers were live and that a further large biopharma customer selected Vault CRM. Live customers, announced selections and revenue are different measures; an announced selection can still take time to deploy.
What remains unproven
Beneficiary: Veeva Systems, selling subscription software for biopharma commercial and development workflows. Proven: company-level subscription sales and reported Vault CRM live deployments. Not proven: the incremental annual recurring revenue, margin or cash from agents specifically, plus how quickly newly selected clients go live. A repeatable multi-year subscription could support future earnings if customers renew; price appreciation is not guaranteed.
What to check before acting
Entry conditions
The US$301.53 reference is an ordinary unadjusted closing market snapshot, not proof of a cheap entry. Study the valuation against GAAP earnings, free-cash-flow margin, share-based compensation and retained subscriptions. Some stock portals show high multiples, which makes even good operations risky if growth slows. No separately reliable AI-attach model was available, so a justified entry discount or numerical fair value is NOT estimated.
Possible upside
Customers adopt paid agent functions at attractive margins and operating cash follows.
Possible downside
Implementation delays, competition or valuation compression could materially reduce the quoted share price.
Price or return range method
Downside: implementation delays, competition or valuation compression could materially reduce the quoted share price. Base case: existing software subscription growth persists, while AI attachment stays small or undisclosed. Upside: customers adopt paid agent functions at attractive margins and operating cash follows. Numerical downside/base/upside price ranges: NOT ESTIMATED, because attach rates, long-term margins and discount-rate assumptions cannot be defended from current disclosures. These are conditional qualitative paths, not guaranteed share prices, profits or investment advice.
Costs and fees
Trading spread, commission, custody and SGD-USD exchange fees vary by broker; applicable investor tax treatment not assessed.
How hard it may be to sell
Exchange-listed shares normally trade during market hours, subject to price gaps, volatility and broker access.
Key risks
Main risk: a strong product story has been fully priced in. Alternative: customer migrations are replacements rather than expansion. Exact disproof: over two successive fiscal reports, subscription growth weakens materially while CRM live deployments/agent products rise but operating cash and renewal measures do not improve. Liquidity: exchange-listed shares normally trade during market hours, subject to price gaps, volatility and broker access. Trading spread, commission, custody and SGD-USD exchange fees vary by broker; applicable investor tax treatment not assessed.
What an ordinary reader can do next
Read Veeva latest earnings and SEC filing, then track the distinction among selected, deployed, renewed, invoiced and collected contracts. Request an actual broker quote and check spreads/fees before any action. Reassess if the next two reports do not quantify the cash consequence of migration and agents. This is not suitable for every reader. Issuer investor calendar listed fiscal-2027 third-quarter results for 3 December 2026; verify that event date again before relying on it. Test actual subscription growth, cash from operations, software margins and commentary about AI products. An announced customer is not a new earned subscription until recognised under accounting rules.
Original forecast record
Original forecast in full
Long Term: Veeva Systems: regulated CRM switching costs
Category: Shares
Exact asset: NYSE: VEEV
Country and currency: United States / USD
Published: 15 November 2026, 15:58 SGT
Information cutoff: 15 November 2026, 15:58 SGT
Main time horizon: 2 years
Current position: RESEARCH WATCH: revenue durability established, incremental AI revenue not isolated
Publication clarification, 16 November 2026 (SGT): The source's Published timestamp above is the dossier issue time, not this website article's first-publication time.
The opportunity in one sentence
If drug makers adopt Vault CRM and Veeva agents together, regulated workflows could lift recurring subscriptions before the separate AI contribution becomes visible in reported cash.
Entry price and date
Reference entry price: US$301.53 per share; observed 13 Nov 2026 at 16:00 EST (14 Nov 2026 at 05:00 SGT). Market: US equity closing snapshot via Stock Analysis; quote type: historical market quote, not an offer or completed purchase. Ordinary-reader availability: the listed share may be available from an authorised broker where supported; check local access, liquidity, prices and fees. Entry note: TRACKING PRICE ONLY. NO ACTUAL PURCHASE. On Sunday 15 November, the US market is closed. The quote source and exact class are frozen in the tracking record below.
What changed?
3 March 2026: Veeva said more than 125 customers were live on Vault CRM. 3 June: it reported fiscal-2027 Q1 revenue of approximately US$882.9m. 26 August: fiscal Q2 revenue rose to approximately US$928m, including US$766.8m subscription revenue. 23 September: Veeva said approximately 190 customers were live and that a further large biopharma customer selected Vault CRM. Live customers, announced selections and revenue are different measures; an announced selection can still take time to deploy.
View chart values
| Quarter | Revenue |
|---|---|
| FY2027 Q1 | 882.9 |
| FY2027 Q2 | 928 |
The connection most people may miss
REPORT A (3 March): more than 125 regulated firms have migrated to a working CRM. -> REPORT B (26 August): subscription revenue is already growing at the issuer level. -> REPORT C (23 September): new commitments may deepen the installed base. HIDDEN TEST: if additional agent features attach to migrations without a proportional rise in implementation cost, Veeva could earn more subscription income per customer. The public reports do not prove that separate agent subscriptions already generate material revenue.
- SelectedAnnounced customer commitment
- DeployedWorking Vault CRM installation
- Renewed and invoicedRetention and paid contract terms need evidence
- CollectedCash receipt and margins need evidence
How this could make money
Beneficiary: Veeva Systems, selling subscription software for biopharma commercial and development workflows. Proven: company-level subscription sales and reported Vault CRM live deployments. Not proven: the incremental annual recurring revenue, margin or cash from agents specifically, plus how quickly newly selected clients go live. A repeatable multi-year subscription could support future earnings if customers renew; price appreciation is not guaranteed.
Why the entry price matters
The US$301.53 reference is an ordinary unadjusted closing market snapshot, not proof of a cheap entry. Study the valuation against GAAP earnings, free-cash-flow margin, share-based compensation and retained subscriptions. Some stock portals show high multiples, which makes even good operations risky if growth slows. No separately reliable AI-attach model was available, so a justified entry discount or numerical fair value is NOT estimated.
Time-horizon forecast
| Horizon | Review date | What we expect or need to see | What would challenge it |
|---|---|---|---|
| 6 months | 2027-05-15 | Count deployed Vault CRM customers in next issuer update | Customer churn or implementation overruns already evident |
| 1 year | 2027-11-15 | Compare new subscriptions and agent product pricing with cash generation | Subscription growth slows while expenses accelerate |
| 2 years | 2028-11-15 | Look for a separately disclosed AI/CRM renewal cohort | Management still does not isolate monetisation |
| 3 years | 2029-11-15 | Look for operating cash growth exceeding equity dilution over two fiscal cycles | Cash growth stalls despite rising reported adjusted metrics |
| 4 years | 2030-11-15 | Test sustained customer retention and returns on product investment | Major customers migrate to alternative software |
| 5 years | 2031-11-15 | Check five-year subscription mix versus competitive pricing pressure | Legacy platform disruption or falling renewal rates |
- Original Veeva dossier, 15 November 2026 15:58 SGT
Possible price outcomes
Downside: implementation delays, competition or valuation compression could materially reduce the quoted share price. Base case: existing software subscription growth persists, while AI attachment stays small or undisclosed. Upside: customers adopt paid agent functions at attractive margins and operating cash follows. Numerical downside/base/upside price ranges: NOT ESTIMATED, because attach rates, long-term margins and discount-rate assumptions cannot be defended from current disclosures. These are conditional qualitative paths, not guaranteed share prices, profits or investment advice.
What could go wrong?
Main risk: a strong product story has been fully priced in. Alternative: customer migrations are replacements rather than expansion. Exact disproof: over two successive fiscal reports, subscription growth weakens materially while CRM live deployments/agent products rise but operating cash and renewal measures do not improve. Liquidity: exchange-listed shares normally trade during market hours, subject to price gaps, volatility and broker access. Trading spread, commission, custody and SGD-USD exchange fees vary by broker; applicable investor tax treatment not assessed.
What an ordinary person can do
Read Veeva latest earnings and SEC filing, then track the distinction among selected, deployed, renewed, invoiced and collected contracts. Request an actual broker quote and check spreads/fees before any action. Reassess if the next two reports do not quantify the cash consequence of migration and agents. This is not suitable for every reader.
What happens next?
Issuer investor calendar listed fiscal-2027 third-quarter results for 3 December 2026; verify that event date again before relying on it. Test actual subscription growth, cash from operations, software margins and commentary about AI products. An announced customer is not a new earned subscription until recognised under accounting rules.
OTR tracking record
Original entry price and date (permanent, frozen field): US$301.53 per share, 13 Nov 2026 16:00 EST, US market closing reference; original source: https://stockanalysis.com/stocks/veev/history/. Latest checked price: same closing price only; no later independent regular-session quote available as of report cutoff. Price change: 0.00% since frozen tracking snapshot only, not an actual investment return. Estimated result after costs: NOT ASSESSABLE; unknown broker spread, commission, custody, FX, distributions and taxes; no costs were incurred by this research. Actually sold? NO, no purchase executed. Forecast status: NOT YET DUE; these are first-publication scenarios. Next review: 2026-12-03. Do not rewrite the frozen original price or forecast when new evidence appears; append a separately dated update.
Dated verification note
Verification, 16 November 2026 (SGT): All eight original URLs reopened. Q1 fiscal-2027 revenue of US$882.9 million and Q2 US$928 million, including US$766.8 million subscription revenue, are reported revenue, not annual recurring revenue or collected cash. March and September deployment counts are issuer claims; selections and available agent products do not establish separate paid agent revenue. The July-period 10-Q describes generally terminable multi-year subscriptions and EU Data Act cancellation rights, so switching costs do not guarantee retention. The frozen US$301.53 is the 13 November 2026, 16:00 EST historical close; US$301.48 at 19:58 EST that date (14 November 08:58 SGT) is a separate after-hours observation, neither an executable entry. A separately checked issuer-issued release dated 12 November confirms planned 3 December results after market close and a 17:00 ET call (4 December 06:00 SGT); this is scheduled, not completed. The direct investor-relations event feed was empty during this check. The original source register below is preserved; the SEC reference date denotes the reporting period, not a verified filing-publication date.
Additional verification source: Veeva scheduled results announcement, 12 November 2026.
Original forecast date and time
2026-11-15T15:58:00+08:00
Forecasts and review dates
6 months
Review date
2027-05-15
Original forecast
Count deployed Vault CRM customers in next issuer update
What to measure
Count deployed Vault CRM customers in next issuer update
What must happen
Count deployed Vault CRM customers in next issuer update
What would challenge the forecast
Customer churn or implementation overruns already evident
Current outcome
Not yet due
1 year
Review date
2027-11-15
Original forecast
Compare new subscriptions and agent product pricing with cash generation
What to measure
Compare new subscriptions and agent product pricing with cash generation
What must happen
Compare new subscriptions and agent product pricing with cash generation
What would challenge the forecast
Subscription growth slows while expenses accelerate
Current outcome
Not yet due
2 years
Review date
2028-11-15
Original forecast
Look for a separately disclosed AI/CRM renewal cohort
What to measure
Look for a separately disclosed AI/CRM renewal cohort
What must happen
Look for a separately disclosed AI/CRM renewal cohort
What would challenge the forecast
Management still does not isolate monetisation
Current outcome
Not yet due
3 years
Review date
2029-11-15
Original forecast
Look for operating cash growth exceeding equity dilution over two fiscal cycles
What to measure
Look for operating cash growth exceeding equity dilution over two fiscal cycles
What must happen
Look for operating cash growth exceeding equity dilution over two fiscal cycles
What would challenge the forecast
Cash growth stalls despite rising reported adjusted metrics
Current outcome
Not yet due
4 years
Review date
2030-11-15
Original forecast
Test sustained customer retention and returns on product investment
What to measure
Test sustained customer retention and returns on product investment
What must happen
Test sustained customer retention and returns on product investment
What would challenge the forecast
Major customers migrate to alternative software
Current outcome
Not yet due
5 years
Review date
2031-11-15
Original forecast
Check five-year subscription mix versus competitive pricing pressure
What to measure
Check five-year subscription mix versus competitive pricing pressure
What must happen
Check five-year subscription mix versus competitive pricing pressure
What would challenge the forecast
Legacy platform disruption or falling renewal rates
Current outcome
Not yet due
Sources
Dated source
Source ID
VEEV-S1
Source link and publication date
1. Fiscal 2027 Q2 results | Veeva | Original: 26 Aug 2026 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-08-26
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Subscription and total revenue; primary earnings source.
Source ID
VEEV-S2
Source link and publication date
2. Fiscal 2027 Q1 results | Veeva | Original: 3 Jun 2026 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-06-03
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Quarterly revenue comparison.
Source ID
VEEV-S3
Source link and publication date
3. 125+ customers live on Vault CRM | Veeva | Original: 3 Mar 2026 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-03-03
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Customer deployment milestone.
Source ID
VEEV-S4
Source link and publication date
4. Vault CRM extends market leadership | Veeva | Original: 23 Sep 2026 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-09-23
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: 190 customer claims and commitments versus live deployments.
Source ID
VEEV-S5
Source link and publication date
5. Veeva AI agents now available | Veeva | Original: 3 Dec 2025 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2025-12-03
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Product availability not proven monetisation.
Source ID
VEEV-S6
Source link and publication date
6. Regeneron selects Vault CRM | Veeva | Original: 25 Aug 2026 | US / English.
Publisher: Veeva
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-08-25
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Selected versus implemented distinction.
Source ID
VEEV-S8
Source link and publication date
8. VEEV dated trading history | Stock Analysis | Original: 13 Nov 2026 quote | US / English.
Publisher: Stock Analysis
Reading access: partial
published date precision: day
retrieved date precision: day
Source publication date 2026-11-13
Source retrieval date 2026-11-16
What this source supports
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Reference market close; not executed trade.
Source limits
Original source register
At least eight asset-relevant references, with full URLs. Source check window: 15 November 2026, 15:58 SGT (edition-level clock; exact upstream HTTP completion time per URL not retained). Link status says whether the page was directly opened, or identified in web search and corroborated with the issuer/index. Dates marked unknown are not invented.
1. Fiscal 2027 Q2 results | Veeva | Original: 26 Aug 2026 | US / English.
Direct URL: https://www.veeva.com/resources/veeva-announces-fiscal-2027-second-quarter-results/
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Subscription and total revenue; primary earnings source.
2. Fiscal 2027 Q1 results | Veeva | Original: 3 Jun 2026 | US / English.
Direct URL: https://www.veeva.com/resources/veeva-announces-fiscal-2027-first-quarter-results/
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Quarterly revenue comparison.
3. 125+ customers live on Vault CRM | Veeva | Original: 3 Mar 2026 | US / English.
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Customer deployment milestone.
4. Vault CRM extends market leadership | Veeva | Original: 23 Sep 2026 | US / English.
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: 190 customer claims and commitments versus live deployments.
5. Veeva AI agents now available | Veeva | Original: 3 Dec 2025 | US / English.
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Product availability not proven monetisation.
6. Regeneron selects Vault CRM | Veeva | Original: 25 Aug 2026 | US / English.
Direct URL: https://www.veeva.com/resources/veeva-vault-crm-selected-by-regeneron/
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Selected versus implemented distinction.
7. Veeva 10-Q July 2026 | US SEC / Veeva | Original: 31 Jul 2026 period | US / English.
Direct URL: https://www.sec.gov/Archives/edgar/data/1393052/000139305226000036/veev-20260731.htm
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Web-retrieved/search-indexed. Supports: Financial and operating risks, actual accounts.
8. VEEV dated trading history | Stock Analysis | Original: 13 Nov 2026 quote | US / English.
Direct URL: https://stockanalysis.com/stocks/veev/history/
Checked: 15 November 2026, 15:58 SGT (edition research window; exact per-URL upstream timestamp unavailable). Verification: Direct page opened. Supports: Reference market close; not executed trade.